These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 9252796

  • 1. Studies to assess if pizotifen prophylaxis improves migraine beyond the benefit offered by acute sumatriptan therapy alone.
    Cleland PG, Barnes D, Elrington GM, Loizou LA, Rawes GD.
    Eur Neurol; 1997; 38(1):31-8. PubMed ID: 9252796
    [Abstract] [Full Text] [Related]

  • 2. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effectiveness of tolfenamic acid in the prevention of migraine].
    Vaitkus A, Pauza V.
    Medicina (Kaunas); 2002 May; 38(3):296-303. PubMed ID: 12474702
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H, Heinze A, Stolze H, Heinze-Kuhn K, Lindner V.
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [Abstract] [Full Text] [Related]

  • 8. Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine.
    Diamond S, Elkind A, Jackson RT, Ryan R, DeBussey S, Asgharnejad M.
    Arch Fam Med; 1998 Sep; 7(3):234-40. PubMed ID: 9596457
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy of nimodipine in comparison with pizotifen in the prophylaxis of migraine.
    Havanka-Kanniainen H, Hokkanen E, Myllylä VV.
    Cephalalgia; 1987 Mar; 7(1):7-13. PubMed ID: 3555838
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA.
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study.
    Tfelt-Hansen P, Bach FW, Daugaard D, Tsiropoulos I, Riddersholm B.
    J Headache Pain; 2006 Dec; 7(6):389-94. PubMed ID: 17164991
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC, Gendolla A, Gebert I, Beneke M.
    Eur Neurol; 2005 Dec; 53 Suppl 1():41-8. PubMed ID: 15920337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.